Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
7700 participants
OBSERVATIONAL
2018-02-04
2021-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of the Duration of Pre-oxygenation on Apnea Tolerance in Obese Patients During the Induction of General Anesthesia
NCT04699435
Breath Monitoring of Propofol (Observational Study)
NCT01892683
VitamIn and oXygen Interventions and Cardiovascular Events
NCT03494387
Risk of Oxygen During Cardiac Surgery Trial
NCT02361944
The Hypotensive Effect of Propofol: an Observational Study
NCT01508351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The odds ratio (OR) for the primary and secondary outcomes will be calculated in a logistic regression analysis with median FiO2 (continuous variable) as independent variable.
Analyses are performed with multiple logistic regression with adjustment for the following potentially confounding variables:
Age ≥75 years. Male sex. Current atrial fibrillation. History of diabetes. History of congestive heart failure. History of coronary artery disease. History of recent (i.e., \< 6 months) high-risk coronary artery disease. History of stroke. History of peripheral vascular disease. History of hypertension. Preoperative eGFR (\<30 vs. 30-44 vs. 45-59 vs. ≥60 mL/min/1.73m2). Low-risk surgery. Duration of surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inspiratory oxygen fraction
Median inspiratory oxygen fraction during general anesthesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with unobtainable data on postoperative troponin.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Population Health Research Institute
OTHER
University Hospital Bispebjerg and Frederiksberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sofie Pedersen
MD, PhD-student at Dept. of Anesthesia and Intensive Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian S. Meyhoff, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University hospital Bispebjerg Frederiksberg
PJ Devereaux, MD, PhD
Role: STUDY_CHAIR
Population Healt Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic
Cleveland, Ohio, United States
Walter C. Mackenzie Health Sciences Centre
Edmonton, , Canada
Prince of Wales Hospital
Hong Kong, , China
Foundation CardioInfanil
Bogotá, , Colombia
Bispebjerg Hospital
Copenhagen, NV, Denmark
Christian Medical College
Ludhiāna, , India
University Malaya Medical Centre
Kuala Lumpur, , Malaysia
Inkosi Albert Luthuli Hospital
Durban, , South Africa
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hyperoxia and MINS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.